United States · 
Who invested in Sagimet Biosciences?
Sagimet Biosciences's investors include Ascletis Pharma.
United States · Series E startup
Who invested in Sagimet Biosciences
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2019, from 1 source
- Latest round
- Series E, $25MAug 2019
- Investors
- 1
The rounds
- Aug 2019
Founders and team
From the SEC filings it signed: 2 on the team.
- Dennis HomExecutive Officeri
- George KembleExecutive Officer, Directori
On the board, as filediBeth SeidenbergGordon RingoldJames YoungJason FullerJinzi Jason WuMerdad ParseyRichard Rodgers
Also claim to have backed them
These 3 firms list Sagimet Biosciences as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Sagimet Biosciences
How much has Sagimet Biosciences raised?
Sagimet Biosciences has raised $25M across 1 round since 2019.
When did Sagimet Biosciences last raise?
Sagimet Biosciences's most recent round was a Series E of $25M in Aug 2019.
What was Sagimet Biosciences's biggest round?
Its most recent round, $25M in Aug 2019, is also its largest on record.
Who backed Sagimet Biosciences first?
Sagimet Biosciences's first round on record, in Aug 2019, was backed by Ascletis Pharma.
What stage is Sagimet Biosciences at?
Sagimet Biosciences's latest named round is a Series E, in Aug 2019.
Where is Sagimet Biosciences based?
Sagimet Biosciences is based in the United States.
Companies like Sagimet Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.